Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Oncology Network Inc. (AONC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/22/2025: AONC (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit 37.63% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/22/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 387.54M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 |
52 Weeks Range 1.08 - 14.05 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.89 |
Earnings Date
Report Date 2025-06-27 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 534565887 | Price to Sales(TTM) 0.22 |
Enterprise Value 534565887 | Price to Sales(TTM) 0.22 | ||
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA 294.53 | Shares Outstanding 29248400 | Shares Floating 8989380 |
Shares Outstanding 29248400 | Shares Floating 8989380 | ||
Percent Insiders 77.99 | Percent Institutions 0.08 |
Upturn AI SWOT
American Oncology Network Inc.
Company Overview
History and Background
American Oncology Network, Inc. (AON) was founded in 2018. It's a physician-led, community-based oncology network focused on providing integrated cancer care services. AON aims to improve patient outcomes and increase access to cancer treatment in local communities.
Core Business Areas
- Oncology Practice Management: AON partners with community oncology practices, providing them with management services, technology, and resources to enhance their operations and patient care.
- Pharmacy and Infusion Services: AON offers integrated pharmacy and infusion services, ensuring patients have access to necessary medications and therapies within the community setting.
- Clinical Research: AON facilitates clinical trials and research initiatives within its network, contributing to advancements in cancer treatment.
Leadership and Structure
AON is led by a management team with experience in oncology, healthcare management, and business development. Its organizational structure includes regional teams and support functions to serve its partner practices.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides a comprehensive suite of practice management services, including financial management, technology solutions, and operational support. The market is highly fragmented, with AON competing with other management service organizations (MSOs). AON's revenue from this segment is hard to determine precisely as it isn't broken out, they boast improved margins for partnered practices.
- Infusion Therapy: AON offers infusion therapy services through its partner practices. This includes chemotherapy and other supportive treatments. Competitors include large hospital systems and independent infusion centers. Data on market share specifically for AON's infusion therapy is not publicly available.
- Oral Oncolytics Dispensing: AON provides oral oncolytics dispensing services within its network. Competitors include large pharmacy chains and specialty pharmacies. Data on market share specifically for AON's dispensing is not publicly available.
Market Dynamics
Industry Overview
The oncology industry is experiencing growth driven by an aging population, increasing cancer incidence, and advancements in treatment options. The market is competitive, with various players, including hospitals, oncology practices, pharmaceutical companies, and technology providers.
Positioning
AON positions itself as a partner to community oncology practices, offering them resources and expertise to compete effectively in the changing healthcare landscape. Its competitive advantage lies in its integrated model and focus on local communities.
Total Addressable Market (TAM)
The total addressable market for oncology care in the US is estimated to be in the hundreds of billions of dollars annually. AON is positioned to capture a portion of this market by partnering with community practices and providing integrated services. TAM estimates vary widely depending on the specific services and geography considered.
Upturn SWOT Analysis
Strengths
- Integrated care model
- Strong physician network
- Technology-enabled platform
- Focus on community oncology
- Scalable business model
Weaknesses
- Dependence on partner practices
- Competition from large hospital systems
- Reimbursement pressures
- Limited brand recognition outside network
- Lack of publicly available detailed financial information
Opportunities
- Expansion into new geographic markets
- Growth in cancer incidence
- Increasing demand for community-based care
- Development of new technologies and services
- Partnerships with pharmaceutical companies
Threats
- Changes in healthcare regulations
- Consolidation in the healthcare industry
- Competition from alternative care models
- Economic downturn
- Drug pricing pressures
Competitors and Market Share
Key Competitors
- US Oncology Network (McKesson) (MCK)
- OneOncology (Private)
- GenesisCare (Private)
Competitive Landscape
AON differentiates itself through its integrated model and focus on community oncology. However, it faces competition from larger, more established players with greater resources and brand recognition. AON needs to continue to show improved efficiencies at smaller clinics for long-term success.
Major Acquisitions
Hematology Oncology of Indiana (HOI)
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: Expanded AON's presence and service offerings in the Indiana market.
Growth Trajectory and Initiatives
Historical Growth: AON has experienced growth through partnerships with community oncology practices. The specific growth rate is not publicly available.
Future Projections: Future growth projections are unavailable due to the lack of public data but expected to grow with demographics and cancer discoveries.
Recent Initiatives: Recent initiatives include expanding its network of partner practices and investing in technology solutions to improve patient care and operational efficiency.
Summary
American Oncology Network is a growing organization focusing on improving cancer care within local communities by partnering with oncology practices. Its integrated model and technology are key strengths, but it competes with larger players and faces reimbursement challenges. Continued expansion and demonstrating value to partner practices will be critical for its success. Future opportunities lie in new markets and tech development.
Peer Comparison
Sources and Disclaimers
Data Sources:
- American Oncology Network Website
- Press Releases
- Industry Reports
- Company Profiles (Where Available)
Disclaimers:
The information provided is based on publicly available data and may not be entirely comprehensive. Financial information is limited due to the company's private status. Market share estimates are approximate and subject to change. This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc.
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-05 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.